AI assistant
Sending…
ANGIODYNAMICS INC — Director's Dealing 2014
Aug 14, 2014
32939_dirs_2014-08-14_bcfc3975-e318-4b6d-8571-f6c92017f261.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2014-07-07
Reporting Person: GOLD JEFFREY (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-07 | Common Stock | M | 6000 | $13.18 | Acquired | 38357 | Direct |
| 2014-07-07 | Common Stock | F | 5405 | $15.90 | Disposed | 32952 | Direct |
| 2014-08-12 | Common Stock | A | 6193 | — | Acquired | 39145 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-07-07 | Non-Qualified Stock Option (right to buy) | $13.18 | M | 6000 | Disposed | 2014-07-20 | Common Stock (6000) | Direct |
| 2014-08-12 | Non-Qualified Stock Option (right to buy) | $14.64 | A | 5726 | Acquired | 2021-08-12 | Common Stock (5726) | Direct |
Footnotes
F1: The acquisition of 6,193 shares of common stock represents 6,193 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in three equal installments beginning on 8/12/2015.
F2: Options for 25% of the shares each became exercisable on 07/20/05, 07/20/06, 07/20/07, and 07/20/08, respectively.
F3: Options for 33 1/3% of the shares are each exercisable on 08/12/2015, 08/12/2016 and 08/12/2017, respectively.
More from ANGIODYNAMICS INC
Regulatory Filings
2026
Apr 23
Interim / Quarterly Report
2026
Apr 2
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Jan 14
Major Shareholding Notification
2026
Jan 8
Regulatory Filings
2026
Jan 6